# Dianthus Therapeutics (DNTH.US)

Canonical: https://gigainvestors.com/s/DNTH

Analysis as of: 2026-10-16T07:28:04.044Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $74.53 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

- [Dan Davidowitz](https://gigainvestors.com/pcm): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Down 30% since Jul 2026 · "Dianthus rises as FDA agrees with proposed changes to lead program" (seekingalpha.com, Mar 2026)

Story as of 2026-10-16T09:58:38.887Z; price observation 2026-10-15.

- 2026-06-15: Dianthus CIDP Data Lift Prospects While Funding And Dilution Risks Linger ([finance.yahoo.com](https://finance.yahoo.com/markets/stocks/articles/dianthus-cidp-data-lift-prospects-110917568.html))

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in biotechnology; annual sales are USD 2 million.

- Source: https://www.sec.gov/Archives/edgar/data/1690585/000169058526000006/dnth-20251231.htm (filed 2026-03-09); FY2025: revenue 2036000; grossProfit 2036000; margin = grossProfit / revenue.

### Where the cash goes

Paid no dividends in 2 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-09); Dividend observations: [[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 0.1% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); DNTH.US SharesStats.PercentInsiders = 0.124 percentage points; cache date 2026-10-16.

### What the price says

The price is 1413.6 times annual sales; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-09); Closing price 74.53 USD; reporting-to-trading FX 1; FY2025 annual sales per share 0.05272210221355145; price multiple 1413.6386234774066. FY2025 cash earnings/share -4.1981398109358485. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2018-06: $13.50 per share

- 2018-07: $13.75 per share

- 2018-08: $14.60 per share

- 2018-09: $12.01 per share

- 2018-10: $8.77 per share

- 2018-11: $9.78 per share

- 2018-12: $5.70 per share

- 2019-01: $7.01 per share

- 2019-02: $13.11 per share

- 2019-03: $16.47 per share

- 2019-04: $14.41 per share

- 2019-05: $14.66 per share

- 2019-06: $14.75 per share

- 2019-07: $13.51 per share

- 2019-08: $10.33 per share

- 2019-09: $10.26 per share

- 2019-10: $10.41 per share

- 2019-11: $13.24 per share

- 2019-12: $15.16 per share

- 2020-01: $11.88 per share

- 2020-02: $11.76 per share

- 2020-03: $6.28 per share

- 2020-04: $8.15 per share

- 2020-05: $8.84 per share

- 2020-06: $7.51 per share

- 2020-07: $7.02 per share

- 2020-08: $7.27 per share

- 2020-09: $6.80 per share

- 2020-10: $6.31 per share

- 2020-11: $7.15 per share

- 2020-12: $7.84 per share

- 2021-01: $8.84 per share

- 2021-02: $10.51 per share

- 2021-03: $11.84 per share

- 2021-04: $11.65 per share

- 2021-05: $12.35 per share

- 2021-06: $9.78 per share

- 2021-07: $7.12 per share

- 2021-08: $6.40 per share

- 2021-09: $7.28 per share

- 2021-10: $6.40 per share

- 2021-11: $5.63 per share

- 2021-12: $4.43 per share

- 2022-01: $3.27 per share

- 2022-02: $3.15 per share

- 2022-03: $2.90 per share

- 2022-04: $1.43 per share

- 2022-05: $1.16 per share

- 2022-06: $1.20 per share

- 2022-07: $1.60 per share

- 2022-08: $1.76 per share

- 2022-09: $1.41 per share

- 2022-10: $1.29 per share

- 2022-11: $1.15 per share

- 2022-12: $0.40 per share

- 2023-01: $0.55 per share

- 2023-02: $0.81 per share

- 2023-03: $0.79 per share

- 2023-04: $0.78 per share

- 2023-05: $0.65 per share

- 2023-06: $0.76 per share

- 2023-07: $0.80 per share

- 2023-08: $0.75 per share

- 2023-09: $13.67 per share

- 2023-10: $12.00 per share

- 2023-11: $11.18 per share

- 2023-12: $10.40 per share

- 2024-01: $19.00 per share

- 2024-02: $24.75 per share

- 2024-03: $30.00 per share

- 2024-04: $21.35 per share

- 2024-05: $21.61 per share

- 2024-06: $25.88 per share

- 2024-07: $29.78 per share

- 2024-08: $28.83 per share

- 2024-09: $27.38 per share

- 2024-10: $27.86 per share

- 2024-11: $23.99 per share

- 2024-12: $21.80 per share

- 2025-01: $22.15 per share

- 2025-02: $21.60 per share

- 2025-03: $18.14 per share

- 2025-04: $21.85 per share

- 2025-05: $17.39 per share

- 2025-06: $18.63 per share

- 2025-07: $20.67 per share

- 2025-08: $23.57 per share

- 2025-09: $39.35 per share

- 2025-10: $34.98 per share

- 2025-11: $43.98 per share

- 2025-12: $41.21 per share

- 2026-01: $53.39 per share

- 2026-02: $55.19 per share

- 2026-03: $83.92 per share

- 2026-04: $87.80 per share

- 2026-05: $93.01 per share

- 2026-06: $97.48 per share

- 2026-07: $106.92 per share

- 2026-08: $105.61 per share

- 2026-09: $88.05 per share

- 2026-10: $74.53 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1690585/000169058526000006/dnth-20251231.htm); period 2025-12-31, filed 2026-03-09.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations

- [Dan Davidowitz](https://gigainvestors.com/pcm): 9,333 DNTH shares; USD 910,000 reported position value; 0.01% of portfolio; add; quarter 2026 Q2.

# DNTH — Dianthus Therapeutics Inc

Held by 1 investor · USD 910,000 total · 2026 Q2 · reported price USD 97.50 (split-adjusted).
Page: https://gigainvestors.com/s/DNTH

## Holders (2026 Q2)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| Dan Davidowitz (https://gigainvestors.com/pcm) | USD 910,000 | <0.1% | add +126.58% |

## Total held by quarter

- 2026 Q1: USD 345,996 · 1 holder · USD 84.00
- 2026 Q2: USD 910,000 · 1 holder · USD 97.50